ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,999.30
-0.23%
S&P ASX All Technology
3,160.00
-0.16%
Brent Oil
83.225
-1.32%
US Dollar vs AUD
1.48464
0.41%
Bitcoin
65,120.57
0.41%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vericel Corporation (VCEL)

  7. Vericel Corporation (VCEL) News

VCEL

Vericel (VCEL)

Vericel Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VCEL
DateTimeSourceHeadlineSymbolCompany
17/07/200621:00PR Newswire (US)George W. Dunbar Joins Aastrom Biosciences as Chief Executive OfficerNASDAQ:VCELVericel Corporation
30/06/200607:05PR Newswire (US)Aastrom Biosciences Achieves U.S. Bone Fracture Clinical MilestoneNASDAQ:VCELVericel Corporation
12/05/200606:50PR Newswire (US)Aastrom Biosciences' CEO to Present at Rodman & Renshaw 3rd Annual Global Healthcare ConferenceNASDAQ:VCELVericel Corporation
10/05/200621:15PR Newswire (US)Aastrom Biosciences Receives Manufacturing License at European Pilot Facility for Production of Proprietary Bone Marrow Stem CeNASDAQ:VCELVericel Corporation
10/05/200621:00PR Newswire (US)Aastrom Biosciences, Inc. Reports Third Quarter Fiscal Year 2006 Financial ResultsNASDAQ:VCELVericel Corporation
05/05/200604:00Business WireWebcast Alert: Aastrom Biosciences Announces Its Third Quarter Investor Conference CallNASDAQ:VCELVericel Corporation
07/04/200600:49PR Newswire (US)Aastrom Biosciences to Raise $25.5 Million in Equity FinancingNASDAQ:VCELVericel Corporation
24/03/200607:00PR Newswire (US)Aastrom Biosciences Receives Orphan Drug Designation from the FDA for Proprietary Bone Marrow CellsNASDAQ:VCELVericel Corporation
22/03/200622:00PR Newswire (US)Aastrom Biosciences' U.S. Clinical Investigator to Report On Long Bone Fracture Repair TrialNASDAQ:VCELVericel Corporation
20/03/200623:00PR Newswire (US)Orthovita and Aastrom Biosciences Announce Collaboration Agreement for Orthopedic ProductsNASDAQ:VCELVericel Corporation
20/03/200623:00Business WireOrthovita and Aastrom Biosciences Announce Collaboration Agreement for Orthopedic Products; Alliance to Combine Aastrom TissueNASDAQ:VCELVericel Corporation
17/03/200607:30PR Newswire (US)Aastrom Biosciences' Delegates to Present at Two Orthopaedic MeetingsNASDAQ:VCELVericel Corporation
08/03/200600:00PR Newswire (US)The Bull Market Report Publishes In-Depth Report on Stem Cell CompaniesNASDAQ:VCELVericel Corporation
03/03/200608:00PR Newswire (US)Aastrom Biosciences CEO to Present at Cowen & Co. 26th Annual Health Care ConferenceNASDAQ:VCELVericel Corporation
13/02/200623:00PR Newswire (US)Nelson M. Sims Joins Aastrom Biosciences' Board of DirectorsNASDAQ:VCELVericel Corporation
08/02/200622:00PR Newswire (US)Aastrom Biosciences, Inc. Reports Second Quarter Fiscal Year 2006 Financial ResultsNASDAQ:VCELVericel Corporation
07/02/200601:00Business WireWebcast Alert: Aastrom Biosciences Announces Its Second Quarter Investor Conference CallNASDAQ:VCELVericel Corporation
17/01/200621:45PR Newswire (US)Robert L. Zerbe, M.D., Joins Aastrom Biosciences' Board of DirectorsNASDAQ:VCELVericel Corporation
29/12/200501:00PR Newswire (US)Aastrom Biosciences Announces Management Succession ProcessNASDAQ:VCELVericel Corporation
21/12/200521:45PR Newswire (US)Aastrom Biosciences Reports Positive Human Jaw Bone Reconstruction Results from Feasibility Clinical TrialNASDAQ:VCELVericel Corporation
13/12/200521:45PR Newswire (US)Aastrom Biosciences Announces Second Clinical Trial for Bone Fractures in SpainNASDAQ:VCELVericel Corporation
30/11/200522:00PR Newswire (US)Aastrom Biosciences to Initiate U.S. Clinical Trial for Bone Formation in Spine Under Approved IND from the FDANASDAQ:VCELVericel Corporation
09/11/200522:00PR Newswire (US)Aastrom Biosciences, Inc. Reports First Quarter Fiscal Year 2006 Financial ResultsNASDAQ:VCELVericel Corporation
08/11/200509:24PR Newswire (US)Aastrom Biosciences CEO to Present at Noble Financial Group Small Cap ConferenceNASDAQ:VCELVericel Corporation
05/11/200502:39Business WireWebcast Alert: Aastrom Biosciences Announces Its First Quarter Investor Conference CallNASDAQ:VCELVericel Corporation
04/11/200507:58PR Newswire (US)Aastrom Biosciences CEO to Present at Rodman & Renshaw Techvest 7th Annual Healthcare ConferenceNASDAQ:VCELVericel Corporation
02/11/200507:08Business WireWebcast Alert: Aastrom Biosciences Announces Webcast of Its Annual Meeting of ShareholdersNASDAQ:VCELVericel Corporation
18/10/200520:45PR Newswire (US)Aastrom Biosciences Receives Phase II NIH Grant to Support Further Development of its Proprietary Stem Cell Manufacturing SystemNASDAQ:VCELVericel Corporation
06/10/200520:45PR Newswire (US)Aastrom Biosciences' Tissue Repair Cells Used in New Clinical Trial for Regeneration of Vascular Tissue in Diabetic PatientsNASDAQ:VCELVericel Corporation
30/09/200521:00PR Newswire (US)Alan L. Rubino Elected to Aastrom Biosciences' Board of DirectorsNASDAQ:VCELVericel Corporation
 Showing the most relevant articles for your search:NASDAQ:VCEL

Your Recent History

COIN
HGTUSD
HelloGold
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved